Khadija

Khadija Imtiyaz is currently working as a PhD scholar at Hassan’s Lab with research primarily focused on discovering and optimizing novel therapeutics to combat cancer. Her areas of interest include computational and experimental approaches, including structure-based drug design, molecular modeling, and preclinical evaluations, to develop targeted and effective therapies.  

 As part of her ongoing research, she is working on a project titled "Structure guided design and development of potential inhibitors of human thymidine kinase 1 for therapeutic targeting of lung cancer", which aims to integrate bioinformatics, AI-driven drug discovery, and translational research, to bridge the gap between computational predictions and clinical applications. She have contributed to scientific literature with several publications. 

(Noor S, Choudhury A, Raza A, Ashraf A, Islam KU, Hussain A, Imtiyaz K, Islam A, Hassan MI. Probing Baicalin as potential inhibitor of Aurora kinase B: A step towards lung cancer therapy. Int J Biol Macromol. 2024 Feb;258(Pt 1):128813. doi: 10.1016/j.ijbiomac.2023.128813. Epub 2023 Dec 18. PMID: 38123032.)